It's not just a weight loss solution
For example, a recent study found that participants were far more likely to lose 10% or more of their body weight on Wegovy while experiencing roughly the same likelihood of the gastrointestinal side effects that are common with GLP-1 drugs
1, New Hampshires Medicaid program will stop covering GLP-1 drugs Wegovy, Zepbound, and others for weight loss
The risk isnt the price, its whether the pharmacy is properly licensed, uses USP 797 sterile compounding, sources API from FDA-registered suppliers, and tests each batch
Some patients may notice changes in sleep, recovery, or energy earlier, while changes in body composition, skin quality, or wellness goals may take longer
Umapathysivam MM, Lee MY, Jones KL, et al